ArticleBMJ mental health2023

Prescription amphetamines in people with opioid use disorder and co-occurring psychostimulant use disorder initiating buprenorphine: an analysis of treatment retention and overdose risk.

Vitor Tardelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.